Critical Care
Dr. Abdulhadi Talal Gelaidan
Consultant Critical Care Medicine
Specialty
Critical Care
Experience
10+ years
Dr. Gelaidan is a Nephrology and Critical Care Medicine consultant at King's College Hospital London in Jeddah, known for his exceptional expertise and compassionate approach to patient care. Dr. Gelaidan specializes in Critical Care Medicine and Nephrology.
Languages spokenEnglish, Arabic
Areas of expertise.
Acute Renal Failure (AKI)Acute Renal Replacement TreatmentAcute Respiratory Failureand holistic care for end-stage renal disease (ESRD)CardiorenalChronic Kidney Disease (CKD)Hepatorenal DisordersLife-Threatening Acute CareManaging Hemodynamically UnstablePreventionprogression managementRenal System DisordersSepsis-related Organ Dysfunction
Conditions and procedures.
- Member in American Thoracic Society (ATS)
- Society of Critical Care Medicine (SCCM)
- European Society of Critical Care Medicine (ESICM)
- American Society of Nephrology (ASN)
- CRRT Academy
- The American College of Chest Physicians (CHEST)
Education and training.
- 01Medical Degree (2006 , 2012): King Abdul-Aziz University, Jeddah, Saudi Arabia
- 02Master of Public Health (2014-2016): University of Miami, Miami, FL, USA
- 03Internal Medicine Residency (2016 , 2019): St. Vincent Hospital (affiliated with University of Massachusetts), Worcester, MA, USA
- 04Nephrology Fellowship (2019-2021): Emory University School of Medicine, Atlanta, GA, USA
- 05Critical Care Medicine Fellowship (2021-2022): Rutgers University, New Brunswick, NJ, USA
Boards and fellowships.
- 01Dubai Health Authority (DHA) medical license (data flow completed but still in process under DHA).
- 02Saudi Commission For Health Specialties, 08/2022.
- 03New Jersey, full medical licenses, USA.
- 04MBBS, King Abdul-Aziz University, Jeddah, Saudi Arabia
- 05Master of Public Health, University of Miami, Miami, FL, USA.
- 06American board of Internal Medicine.
- 07American board of Nephrology.
- 08American Fellowship in Critical Care Medicine.
Selected publications.
- 01Abdulhadi T Gelaidan, MPH, MD, Janice Lea, MD, Jesse J. Waggoner, MD and Jason Cobb MD. SARS-CoV-2 Not Detected in Peritoneal Effluent in COVID-19 End-Stage Kidney Disease (ESKD) Peritoneal Dialysis Patient. National Kidney Foundation , February 5th 2021.
- 02Abdulhadi T. Gelaidan, Saud O. Abaalkhail, Sheryl C. Caberto. Renal Limited Lupus Like Nephritis In Elderly Male. American Society of Nephrology , August 14th 2020.
- 03Abdulhadi T. Gelaidan, Pooja D. Amarapurkar, Jonathan J. Suarez. Continuous Renal Replacement Therapy (CRRT) for overcorrection of Hyponatremia after Left Ventricular Assistance Device (LVAD) Placement. American Society of Nephrology , August 14th 2020.
- 04Abdulhadi T. Gelaidan, Ajai S. Rajabalan, Janice P. Lea, Jose E. Navarrete, Jason Cobb Quality Improvement Project: Examining Urine Sediment and Microscopic Finding in COVID 19 Acute Kidney Injury Patients. Journal of the American Society of Nephrology , August 14th 2020.
- 05Gelaidan A, Black R, Ghaffar A, Efe O, Bandari B. (available on 2018, October 5) Low serum albumin and hospitalization among end stage renal disease patients on dialysis. Published in American Society of Nephrology.
PATIENT PATHWAY
What an appointment looks like.
01
Inquiry
Self-book or speak with our care team to choose a clinic time.
02
Initial consultation
A full review of history, examination and any same-day diagnostics.
03
Diagnostics & plan
Imaging or labs as needed, then a clear written treatment plan.
04
Follow-up
Structured follow-up, telemedicine if appropriate, dedicated coordinator.
FAQ
Common questions before booking.
OTHER CONSULTANTS

